First patients to test experimental cancer drug FP008
Disease control
Recruiting now
This is the first time researchers are testing the experimental drug FP008 in people with advanced solid tumors. The study aims to find a safe dose and see how the body processes the drug. It will also check if the drug shows any early signs of helping control cancer in patients …
Phase: PHASE1 • Sponsor: Zhuhai Fapon Biopharma Co., Ltd. • Aim: Disease control
Last updated Feb 23, 2026 14:57 UTC